Johnson & Johnson Says Its Booster Shot Provides Increased Protection From COVID-19
Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.